Académique Documents
Professionnel Documents
Culture Documents
REVIEW
Open Access
Abstract
Multiple sclerosis (MS) is the most common chronic inflammatory disorder of the central nervous system (CNS) in
young adults. The disease causes a wide range of symptoms depending on the localization and characteristics of
the CNS pathology. In addition to drug-based immunomodulatory treatment, both drug-based and non-drug
approaches are established as complementary strategies to alleviate existing symptoms and to prevent secondary
diseases. In particular, physical therapy like exercise and physiotherapy can be customized to the individual
patients needs and has the potential to improve the individual outcome. However, high quality systematic data on
physical therapy in MS are rare. This article summarizes the current knowledge on the influence of physical activity
and exercise on disease-related symptoms and physical restrictions in MS patients. Other treatment strategies such
as drug treatments or cognitive training were deliberately excluded for the purposes of this article.
Keywords: Multiple sclerosis, Physical therapy, Exercise, Prevention of sequelae, Personalized treatment
Background of MS
MS is a chronic inflammatory disease of the CNS, which
causes multifocal demyelination along with astrocytic
gliosis and variable axon loss in the brain and spine. MS
is one of the most common causes of non-traumatic
disability in young adults and approximately 1-2.5 million people around the world are estimated to be
affected, depending on the publication [1,2]. Women are
more likely to develop the disease than men (female:
male ratio approximately 2-3:1). MS usually manifests
between the age of 20 to 40 years, rarely much earlier
during childhood, or in old age. The disease course is
usually relapsing-remitting with progression into a secondary progressive form after a varying period of time
or primary progressive right from the start. The precise
etiology of MS still remains unclear. A combination of
environmental and genetic factors which lead to autoimmune reactions against CNS-structures which in turn
result in CNS tissue damage and neurological impairment is assumed to be the most likely pathomechanism
[2,3].
* Correspondence: andrea.doering@charite.de
2
NeuroCure Clinical Research Center and Clinical and Experimental Research
Center for Multiple Sclerosis, Charit - Universittsmedizin Berlin, Charitplatz
1, 10117 Berlin, Germany
Full list of author information is available at the end of the article
2011 Dring et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
Definitions
For the purpose of this article the terms movement,
physical activity, exercise, physical function, physical
therapy, physiotherapy and sport will be used according
to the following definitions (Tables 1 and 2): In terms of
the motor system, the term movement includes an
actively or passively induced change in the position of
the body. Regular exercise and physical activity are decisive factors in a persons quality of life by sustainably
improving health and wellbeing and preventing diseases
at all stages of life. As opposed to sport, in which the
focus is on physical achievement, competition and fun,
physical activity encompasses any type of physical movements, which consume energy, regardless of the underlying motivation. The term health-enhancing physical
activity includes both leisure-time activities (e.g. sport)
and everyday activities (e.g. climbing stairs). The intensity of the activity is categorized according to the metabolic equivalent (MET; 1 MET corresponds to the
oxygen uptake of an adult whilst sitting = 3.5 ml (men)
Page 2 of 13
Figure 1 Drug-based and non-drug-based symptomatic treatment approaches for MS complement each other in almost every stage
of disease. Drug-based strategies encompass basic treatments (interferon-b or glatriameracetete) and if these drugs are not sufficiently
effective escalation therapy with immunosuppressive substances (mitoxantrone), monoclonal antibodies (natalizumab) or sphingosinphosphat
receptor modulator fingolimod. Non-drug strategies like physical therapy (physiotherapy, ergotherapy, logopedics, rehabilitaton) and
occupational therapy (sociotherapy and psychotherapy) are used complementarily in all stages of the disease
Page 3 of 13
A series of increasing steps, with the highest level consisting of the most advanced activities of daily life, the fulfillment of social
roles and the pursuit of recreational activities
Exercise
Planned performance of systematically repeated movements to accomplish skills, maintain and strengthen physical condition, and
improve performance
Sport
Moderate endurance training resulted in improved muscle strength of both lower and upper extremities and
Page 4 of 13
Author
Method
(Major) Endpoints
Sample
size
EDSS
Main Results
Comments
Aerobic
training
Newman
[27]
Treadmill walking
Gait parameters,
Fatigue
16
<7
Repeated
measures design
and blinded
assessments
Pilutti [32]
Body-weight
supported treadmill
training (BWSTT)
Functional ability,
quality of life,
Fatigue
5,5-8
Patients with
progressive MS of
high disability
Rampello
[42]
Aerobic training
program compared
with neurological
rehabilitation
Walking parameters,
maximal exercise
tolerance, quality of
life, fatigue
19
<6
Improvements in some
functional abilities and some
parameters of quality of life,
Fatigue non-significantly
reduced
Improvements of some
walking parameters after
aerobic training, Fatigue
after aerobic training and
neurological rehabilitation
comparable
Schulz [44]
Aerobic training
Immune-endocrine
parameters,
neurotrophic factors,
quality of life,
coordinative
function
67
<5
Van den
Berg [47]
Aerobic treadmill
training
Walking parameters,
fatigue
19
Walk 10 m in
60 s, using aid
if necessary
Improvements of some
walking parameters after
aerobic treadmill training,
fatigue not significantly
reduced
Prospective,
randomized
controlled trial
with blinded
assessments, 16
patients
completed
Mostert
[48]
Aerobic training
26
<6.5
Improvement of health
perception, activity level
Randomized trial
Dodd [28]
Progressive
resistance
strengthening
Aerobic fitness,
fatigue, health
perception, activity
level
Physical,
psychological, social
factors
Muscle strength,
functional capacity
38
3-5.5
Muscle strength,
functional activities
19
White [30]
Progressive
resistance training
Taylor [40]
Progressive
resistance training
Lower extremity
8
strength, ambulatory
function, fatigue,
disability
9
Maximal muscle
force, muscle
endurance,
functional activity,
psychological
function
Gutierrez
[49]
Resistance training
Kinematic gait
8
parameters, isometric
strength, stepping,
fatigue, disability
2.5-5.5
Broekmans
[101]
Resistance training
Muscle strength,
functional mobility
2-6.5
Improvements in muscle
strength and some
functional parameters
Resistance
Training
36
Only 11 patients
completed
Randomized
controlled trial,
long-term
investigation (20
weeks)
Page 5 of 13
Others
Romberg
[34]
Strength, aerobic
training
Walking speed,
95
lower extremity
strength, upper
extremity endurance,
dexterity, static
balance
1-5.5
Cakit [35]
Cycling progressive
resistance training,
balance exercises
Walking parameters, 45
balance, fatigue, fear
of falling, depression,
quality of life
Randomized (two
exercise training
and one control
group), only 33
patients
completed
Smith [46]
Strengthening,
stretches, fitness
exercises
Function, fatigue,
sensory symptoms
34
0-6
Single exercise
session with
follow up, all
measures selfrated
Surakka
[50]
95
1-5.5
Randomized
controlled trial
Motl [17]
Wearing an
accelerometer
292
No specific
training-protocol,
completed selfreport measures
112
0-6.5
Improvements in training
groups with different impact
on parameters, fatigue
reduced
Randomized
(three exercise
training and one
control group),
only 95 patients
completed
42
4.0-5.5
Improvements in mobility,
subjective wellbeing, and
mood
Randomized
controlled
crossover trial
Physical activity,
quality of life,
disability, fatigue,
mood, pain, selfefficacy, social
support
Rasova [43] Neurophysiologically Impairment,
based physiotherapy, disability, handicap,
aerobic training,
quality of life,
combined therapy
fatigue, depression,
respiratory function,
physical fitness
Wiles [51]
Physiotherapy
Mobility, mood
6-month exercise
program,
randomized study,
91 patients
completed
exercise for recovery, and 3. increase the load as the ability to generate muscle force development [40].
Cakit et al. examined the effect of PRE by means of
cycling progressive resistance training and lower-limb
strengthening, both combined with balance exercise in a
prospective randomized controlled trial of 45 MS
patients [35]. After 8 weeks, patients in the two training
groups performed better with respect to 10 m walking
test, duration of exercise, and timed up and go test than
patients in the control group who received no intervention. Moreover, the training groups showed evidence for
superior effects on balance, fatigue, depression, and fear
of falling.
Taylor et al. investigated the effect of a 10 week PRE
program on maximal muscle force, muscle endurance,
functional activity, and overall psychological function in
MS patients [40]. The authors reported significant
improvements of arm strength, leg endurance, and fast
walking speed, and a trend towards improvement in the
2-min walk-test and day-to-day life function.
Besides PRE, other training forms like strategies to
promote proper gait mechanics, focusing on weight
bearing, weight shifting, and body positioning, or weightlifting are used [49]. For example, Pilutti et al. examined the effect of resistance exercise in six severely
disabled patients (EDSS 5-8) with progressive MS (five
patients with primary progressive, one patient with secondary progressive disease course) by means of a 12
week course of body-weight supported treadmill training
performed three times weekly for 30 min [32]. The
patients improved in terms of training intensity treadmill walking speed and required body weight support as
well as in physical and mental subscales of a quality of
life questionnaire. Fatigue was not reduced.
Combined endurance and resistance training
Only few authors examined the effect of combined resistance and endurance training in MS. Small improvements both in muscle strength and gait velocity have
been described [14,34,50]. Interestingly, in a comparatively large study on 95 MS patients, Surakka et al.
observed significant training effects after six months of
combined resistance and endurance training only in
women, but not in men, which might be explained by a
25% higher exercise activity in women [50]. Furthermore, Romberg et al. reported significant improvements
in walking speed and upper extremity endurance following six months combined exercise training, whereas
lower extremity strength, VO2-max, static balance, and
manual dexterity did not improve [34].
In 2005, the Cochrane Collaboration published a first
systematical review on the effects of exercise on ADL
and health-related quality of life (HRQoL) and the
effects of physical therapy on various symptoms in MS
Page 6 of 13
patients [33]. Only controlled, randomized clinical studies on adult MS patients not experiencing an exacerbation at the time were included. Six studies, of which
four have so far only been published as an abstract, analyzed the effects of physical therapy (rehabilitation, physiotherapy, exercise, functional training, independent
home-based training, aquatic exercise) on several disease-related variables compared to a control group that
had not received any physical therapy [36,39,41,51-53].
Three other studies compared the results of two different physical therapy programs. In summary, muscle
strength, movement (changing and maintaining posture,
walking, moving around, timed transfer, walking
cadence), and exercise tolerance tests (modified graded
exercise test, VO2-max, and physiological cost index) all
showed substantial improvement. Mood parameters
(fear, depression) showed only moderate improvement
and EDSS, fatigue, cognitive parameters and ADL
remained unchanged [18,37,48].
Asano et al. assessed the methodological quality of
selected randomized controlled trials (RCT) of exercise
interventions in MS carried out from 1950 to 2007 [29].
They found evidence for positive effects of exercise on
physical and psychosocial functioning and quality of life,
but highlighted a great need for high quality RCTs in
this field.
Exercise in MS patients the impact of body temperature
on disability
It is well known that exercise may influence susceptibility to common infectious diseases like upper respiratory
tract infections in different directions [58]. Whereas vigorous physical activity such as competitive sport can
lead to an increased susceptibility to infections, moderate exercise may contribute to their prevention
[15,19,57-59].
On the immune cell level, physical strain in healthy
subjects has been demonstrated to initially increase the
peripheral lymphocyte count which subsequently falls to
below the initial level after cessation of the physical
activity [19,60,61]. The resulting lymphocyte reduction
was short-lasting with a maximum duration of 3-24 h
[19,58,60] and was shown to be more prominent in Th1
cells than in Th2 cells [61-63]. As Th1 cells primarily
secrete pro-inflammatory cytokines like IFN-g, IL-2, and
TNF-a whereas Th2 rather secrete anti-inflammatory
cytokines such as IL-4, IL-5 and IL-10, exercise can promote a shift from a Th1-mediated pro-inflammatory to
a rather anti-inflammatory Th2-mediated cytokine
milieu [58,60] which is of particular interest because an
imbalance of Th1- and Th2-cells is considered relevant
in MS pathogenesis [62].
Since established immunomodulatory drugs such as
IFN-b or glatiramer acetate exert similar effects on the
immune system, drug treatment and physical activity
may complement each other in terms of modulating the
immune system. The only short lasting effects of exercise on the immune cell level argue for regular and frequent training intervals.
The effect of exercise on cytokine production and
response is less clear and often contradictory
[44,60,62,64], which can in part be explained by different populations studied, different training protocols
and/or different readout parameters and paradigms. For
example, Heesen et al. found similar resting serum concentrations of IFN- g, TNF- a and IL-10 in trained and
untrained MS patients [62], whereas White et al.
reported reduced resting plasma concentrations of IL-4,
IL-10, C-reactive protein (CRP) and IFN- g and a tendency for decreased TNF- a in MS patients upon eight
weeks of PRE. Muscle contractions are thought to stimulate secretion of IL-6 [44,65]. Likewise, contradictory
data have been published on the effect of exercise on
immunoregulatory IL-6 in MS patients [44,64].
Given the neurodegenerative component of MS, the
effect of physical activity, particularly of exercise on
nerve growth factors is of particular importance. In
Page 7 of 13
Page 8 of 13
Page 9 of 13
With a lifetime prevalence of about 90% spasticity is frequent in MS and has a potential to significantly reduce
quality of life [104]. It leads to limitations in the range
and normal pursuit of movements, results in malpositioning of the joints, and is often accompanied by pain
[24]. Controlled studies on exercise and physiotherapy
for MS-related spasticity are rare; however some evidence for improvements has been reported [104].
Physical therapy measures include active and passive
exercise (e.g. targeted positioning of the patient, passive
exercise using motorized cycles, active treadmill exercise) which can be assisted by a training partner or
training equipment such as elastic bands. Physiotherapeutic techniques according to Bobath or Vojta and proprioceptive neuromuscular facilitation (PNF) are among
the treatments applied. None of these measures has
been proven to be superior [104,107]. It is most important to carry them out regularly and with a sufficient
intensity [4,104]. Light stretching of the affected muscle
groups with duration of approximately 20-60 s should
be performed prior to and after exercise [15].
Pareses
Pareses lead to various physical disabilities, such as difficulty in walking and fine-motor dysfunction. A relationship between gait speed and muscle strength in MS
patients has been shown [14]. As no drug treatment for
pareses exists and antispastic drugs such as baclofen
may also lead to a worsening of existing pareses, physical and occupational therapy techniques are the sole
treatment option. Because of reduced impact of gravity
aquatic training allows patients with even severe pareses
of the lower extremities to perform standing and moving exercises [15,16]. A standing frame can help patients
who are unable to stand, to train torso, limb, and
respiratory muscles and protects against cardiovascular
dysregulation. For immobilized patients, passive range of
motion exercises proximal to the paralyzed region is
recommended [15,16]. Various studies have shown a significant improvement of muscle strength due to exercise
[33,35,40,101]. Furthermore some authors reported beneficial effects in walking speed, stepping endurance, stair
climbing, and timed up and go test [35,40,49]. In summary, evidence suggests that exercise is beneficial in the
treatment of MS-related pareses, however again, only
few, partially inconsistent data are available. Moreover,
effects of exercise have been studied almost exclusively
in MS patients with mild or moderate impairment.
Page 10 of 13
Open Access
This article is distributed under the terms of the Creative Commons Attribution Noncommercial License
which permits any noncommercial use, distribution, and
reproduction in any medium, provided the original
author(s) and source are credited.
Acknowledgements
This work was supported by the DFG (Exc 257).
Author details
1
National Representative of EPMA in Germany. 2NeuroCure Clinical Research
Center and Clinical and Experimental Research Center for Multiple Sclerosis,
Charit - Universittsmedizin Berlin, Charitplatz 1, 10117 Berlin, Germany.
Conflicts of interests
The authors declare that they have no competing interests.
Received: 3 August 2011 Accepted: 2 December 2011
Published: 24 December 2011
References
1. Kantarci O, Wingerchuk D: Epidemiology and natural history of multiple
sclerosis: new insights. Curr Opin Neurol 2006, 19(3):248-54.
2. Compston A, Coles A: Multiple sclerosis. Lancet 2002, 359(9313):1221-31.
3. Compston A, Coles A: Multiple sclerosis. The Lancet 2008,
372(9648):1502-17.
4. Henze T, Rieckmann P, Toyka KV: Symptomatic treatment of multiple
sclerosis. Multiple Sclerosis Therapy Consensus Group (MSTCG) of the
German Multiple Sclerosis Society. Eur Neurol 2006, 56(2):78-105.
5. Cattaneo D, Jonsdottir J, Zocchi M, Regola A: Effects of balance exercises
on people with multiple sclerosis: a pilot study. Clin Rehabil 2007,
21(9):771-81.
6. Darley FL, Brown JR, Goldstein NP: Dysarthria in multiple sclerosis. J
Speech Hear Res 1972, 15(2):229-45.
7. DasGupta R, Fowler CJ: Bladder, bowel and sexual dysfunction in multiple
sclerosis: management strategies. Drugs 2003, 63(2):153-66.
8. Fisk JD, Pontefract A, Ritvo PG, Archibald CJ, Murray TJ: The impact of
fatigue on patients with multiple sclerosis. Can J Neurol Sci 1994,
21(1):9-14.
9. MacAllister WS, Krupp LB: Multiple sclerosis-related fatigue. Phys Med
Rehabil Clin N Am 2005, 16(2):483-502.
10. Krupp LB, Alvarez LA, LaRocca NG, Scheinberg LC: Fatigue in multiple
sclerosis. Arch Neurol 1988, 45(4):435-7.
11. Ziemssen T: Multiple sclerosis beyond EDSS: depression and fatigue. J
Neurol Sci 2009, 277(Suppl 1):S37-41.
12. DeSousa EA, Albert RH, Kalman B: Cognitive impairments in multiple
sclerosis: a review. Am J Alzheimers Dis Other Demen 2002, 17(1):23-9.
13. Chiaravalloti ND, DeLuca J: Cognitive impairment in multiple sclerosis.
Lancet Neurol 2008, 7(12):1139-51.
14. Dalgas U, Stenager E, Ingemann-Hansen T: Multiple sclerosis and physical
exercise: recommendations for the application of resistance-, enduranceand combined training. Mult Scler 2008, 14(1):35-53.
15. White LJ, Dressendorfer RH: Exercise and multiple sclerosis. Sports Med
2004, 34(15):1077-100.
16. Petajan JH, White AT: Recommendations for physical activity in patients
with multiple sclerosis. Sports Med 1999, 27(3):179-91.
17. Motl RW, McAuley E, Snook EM, Gliottoni RC: Physical activity and quality
of life in multiple sclerosis: intermediary roles of disability, fatigue,
mood, pain, self-efficacy and social support. Psychol Health Med 2009,
14(1):111-24.
18. Solari A, Filippini G, Gasco P, Colla L, Salmaggi A, La Mantia L, Farinotti M,
Eoli M, Mendozzi L: Physical rehabilitation has a positive effect on
disability in multiple sclerosis patients. Neurology 1999, 52(1):57-62.
19. Waschbisch A, Tallner A, Pfeifer K, Murer M: Multiple sclerosis and
exercise: effects of physical activity on the immune system. Nervenarzt
2009, 80(6):688-92.
20. Thompson AJ, Toosy AT, Ciccarelli O: Pharmacological management of
symptoms in multiple sclerosis: current approaches and future
directions. Lancet Neurol 2010, 9(12):1182-99.
21. Wiendl H, Toyka KV, Rieckmann P, Gold R, Hartung H-P, Hohlfeld R: Basic
and escalating immunomodulatory treatments in multiple sclerosis:
current therapeutic recommendations. J Neurol 2008, 255(10):1449-63.
22. Mendes A, S MJ: Classical immunomodulatory therapy in multiple
sclerosis: how it acts, how it works. Arq Neuropsiquiatr 2011, 69(3):536-43.
23. Thompson AJ: Neurorehabilitation in multiple sclerosis: foundations, facts
and fiction. Curr Opin Neurol 2005, 18(3):267-71.
24. Kesselring J, Beer S: Symptomatic therapy and neurorehabilitation in
multiple sclerosis. Lancet Neurol 2005, 4(10):643-52.
Page 11 of 13
25. White LJ, McCoy SC, Castellano V, Ferguson MA, Hou W, Dressendorfer RH:
Effect of resistance training on risk of coronary artery disease in women
with multiple sclerosis. Scand J Clin Lab Invest 2006, 66(4):351-5.
26. Gallien P, Nicolas B, Robineau S, Ptrilli S, Houedakor J, Durufle A: Physical
training and multiple sclerosis. Ann Readapt Med Phys 2007, 50(6):373-6,
369-372.
27. Newman MA, Dawes H, van den Berg M, Wade DT, Burridge J, Izadi H: Can
aerobic treadmill training reduce the effort of walking and fatigue in
people with multiple sclerosis: a pilot study. Mult Scler 2007, 13(1):113-9.
28. Dodd KJ, Taylor NF, Denisenko S, Prasad D: A qualitative analysis of a
progressive resistance exercise programme for people with multiple
sclerosis. Disabil Rehabil 2006, 28(18):1127-34.
29. Asano M, Dawes DJ, Arafah A, Moriello C, Mayo NE: What does a
structured review of the effectiveness of exercise interventions for
persons with multiple sclerosis tell us about the challenges of designing
trials? Mult Scler 2009, 15(4):412-21.
30. White LJ, McCoy SC, Castellano V, Gutierrez G, Stevens JE, Walter GA, et al:
Resistance training improves strength and functional capacity in persons
with multiple sclerosis. Mult Scler 2004, 10(6):668-74.
31. Dalgas U, Stenager E, Jakobsen J, Petersen T, Hansen HJ, Knudsen C, et al:
Resistance training improves muscle strength and functional capacity in
multiple sclerosis. Neurology 2009, 73(18):1478-84.
32. Pilutti LA, Lelli DA, Paulseth JE, Crome M, Jiang S, Rathbone MP, et al:
Effects of 12 weeks of supported treadmill training on functional ability
and quality of life in progressive multiple sclerosis: a pilot study. Arch
Phys Med Rehabil 2011, 92(1):31-6.
33. Rietberg MB, Brooks D, Uitdehaag BMJ, Kwakkel G: Exercise therapy for
multiple sclerosis. Cochrane Database Syst Rev 2005, 1:CD003980.
34. Romberg A, Virtanen A, Ruutiainen J, Aunola S, Karppi S-L, Vaara M, et al:
Effects of a 6-month exercise program on patients with multiple
sclerosis: a randomized study. Neurology 2004, 63(11):2034-8.
35. Cakit BD, Nacir B, Gen H, Saraolu M, Karagz A, Erdem HR, et al: Cycling
progressive resistance training for people with multiple sclerosis: a
randomized controlled study. Am J Phys Med Rehabil 2010, 89(6):446-57.
36. DeBolt LS, McCubbin JA: The effects of home-based resistance exercise
on balance, power, and mobility in adults with multiple sclerosis. Arch
Phys Med Rehabil 2004, 85(2):290-7.
37. Lord SE, Wade DT, Halligan PW: A comparison of two physiotherapy
treatment approaches to improve walking in multiple sclerosis: a pilot
randomized controlled study. Clin Rehabil 1998, 12(6):477-86.
38. Kileff J, Ashburn A: A pilot study of the effect of aerobic exercise on
people with moderate disability multiple sclerosis. Clin Rehabil 2005,
19(2):165-9.
39. Harvey L, Smith AD, Jones R: The effect of weighted leg raises on
quadriceps strength, EMG parameters and functional activities in people
with multiple sclerosis. Physiotherapy 1999, 85(3):154-61.
40. Taylor NF, Dodd KJ, Prasad D, Denisenko S: Progressive resistance exercise
for people with multiple sclerosis. Disabil Rehabil 2006, 28(18):1119-26.
41. Petajan JH, Gappmaier E, White AT, Spencer MK, Mino L, Hicks RW: Impact
of aerobic training on fitness and quality of life in multiple sclerosis. Ann
Neurol 1996, 39(4):432-41.
42. Rampello A, Franceschini M, Piepoli M, Antenucci R, Lenti G, Olivieri D, et al:
Effect of aerobic training on walking capacity and maximal exercise
tolerance in patients with multiple sclerosis: a randomized crossover
controlled study. Phys Ther 2007, 87(5):545-55.
43. Rasova K, Havrdova E, Brandejsky P, Zlisov M, Foubikova B, Martinkova P:
Comparison of the influence of different rehabilitation programmes on
clinical, spirometric and spiroergometric parameters in patients with
multiple sclerosis. Mult Scler 2006, 12(2):227-34.
44. Schulz K-H, Gold SM, Witte J, Bartsch K, Lang UE, Hellweg R, et al: Impact of
aerobic training on immune-endocrine parameters, neurotrophic factors,
quality of life and coordinative function in multiple sclerosis. J Neurol Sci
2004, 225(1-2):11-8.
45. Stroud NM, Minahan CL: The impact of regular physical activity on
fatigue, depression and quality of life in persons with multiple sclerosis.
Health Qual Life Outcomes 2009, 7:68.
46. Smith RM, Adeney-Steel M, Fulcher G, Longley WA: Symptom change with
exercise is a temporary phenomenon for people with multiple sclerosis.
Arch Phys Med Rehabil 2006, 87(5):723-7.
47. van den Berg M, Dawes H, Wade DT, Newman M, Burridge J, Izadi H, et al:
Treadmill training for individuals with multiple sclerosis: a pilot
randomised trial. J Neurol Neurosurg Psychiatr 2006, 77(4):531-3.
48. Mostert S, Kesselring J: Effects of a short-term exercise training program
on aerobic fitness, fatigue, health perception and activity level of
subjects with multiple sclerosis. Mult Scler 2002, 8(2):161-8.
49. Gutierrez GM, Chow JW, Tillman MD, McCoy SC, Castellano V, White LJ:
Resistance training improves gait kinematics in persons with multiple
sclerosis. Arch Phys Med Rehabil 2005, 86(9):1824-9.
50. Surakka J, Romberg A, Ruutiainen J, Aunola S, Virtanen A, Karppi S-L, et al:
Effects of aerobic and strength exercise on motor fatigue in men and
women with multiple sclerosis: a randomized controlled trial. Clin Rehabil
2004, 18(7):737-46.
51. Wiles CM, Newcombe RG, Fuller KJ, Shaw S, Furnival-Doran J, Pickersgill TP,
et al: Controlled randomised crossover trial of the effects of
physiotherapy on mobility in chronic multiple sclerosis. J Neurol
Neurosurg Psychiatr 2001, 70(2):174-9.
52. Carter P, White CM: The effect of a general exercise training on effort of
walking in patients with multiple sclerosis. International World
Confederation for Physical Therapy. Barcelona 2003 [http://www.wcpt.org/
abstracts2003/common/abstracts/1517. html].
53. OConnell R, Murphy RM, Hutchinson M, Cooke G, Cootes S: A controlled
study to assess the effects of aerobic training on patients with multiple
sclerosis. 14th International World Confederation for Physical Therapy.
Barcelona 2003 [http://www. wcpt.org/abstracts2003/common/abstracts/
2105.html].
54. Guthrie TC, Nelson DA: Influence of temperature changes on multiple
sclerosis: critical review of mechanisms and research potential. J Neurol
Sci 1995, 129(1):1-8.
55. White AT, Wilson TE, Davis SL, Petajan JH: Effect of precooling on physical
performance in multiple sclerosis. Mult Scler 2000, 6(3):176-80.
56. Rasminsky M: The effects of temperature on conduction in demyelinated single nerve fibers. Arch Neurol 1973, 28(5):287-92.
57. Schulz K-H, Heesen C: Effects of exercise in chronically ill patients.
Examples from oncology and neurology. Bundesgesundheitsblatt
Gesundheitsforschung Gesundheitsschutz 2005, 48(8):906-13.
58. Gleeson M: Immune function in sport and exercise. J Appl Physiol 2007,
103(2):693-9.
59. Gold SM, Schulz K-H, Hartmann S, Mladek M, Lang UE, Hellweg R, et al:
Basal serum levels and reactivity of nerve growth factor and brainderived neurotrophic factor to standardized acute exercise in multiple
sclerosis and controls. J Neuroimmunol 2003, 138(1-2):99-105.
60. White LJ, Castellano V: Exercise and brain health-implications for multiple
sclerosis: Part II-immune factors and stress hormones. Sports Med 2008,
38(3):179-86.
61. Steensberg A, Toft AD, Bruunsgaard H, Sandmand M, Halkjaer-Kristensen J,
Pedersen BK: Strenuous exercise decreases the percentage of type 1 T
cells in the circulation. J Appl Physiol 2001, 91(4):1708-12.
62. Heesen C, Gold SM, Hartmann S, Mladek M, Reer R, Braumann K-M, et al:
Endocrine and cytokine responses to standardized physical stress in
multiple sclerosis. Brain Behav Immun 2003, 17(6):473-81.
63. Lancaster GI, Halson SL, Khan Q, Drysdale P, Wallace F, Jeukendrup AE, et al:
Effects of acute exhaustive exercise and chronic exercise training on
type 1 and type 2 T lymphocytes. Exerc Immunol Rev 2004, 10:91-106.
64. Castellano V, Patel DI, White LJ: Cytokine responses to acute and chronic
exercise in multiple sclerosis. J Appl Physiol 2008, 104(6):1697-702.
65. Ozenci V, Kouwenhoven M, Link H: Cytokines in multiple sclerosis:
methodological aspects and pathogenic implications. Mult Scler 2002,
8(5):396-404.
66. Vaynman S, Ying Z, Gomez-Pinilla F: Hippocampal BDNF mediates the
efficacy of exercise on synaptic plasticity and cognition. Eur J Neurosci
2004, 20(10):2580-90.
67. White LJ, Castellano V: Exercise and brain health-implications for multiple
sclerosis: Part 1-neuronal growth factors. Sports Med 2008, 38(2):91-100.
68. Trejo JL, Carro E, Torres-Aleman I: Circulating insulin-like growth factor I
mediates exercise-induced increases in the number of new neurons in
the adult hippocampus. J Neurosci 2001, 21(5):1628-34.
69. Lopez-Lopez C, LeRoith D, Torres-Aleman I: Insulin-like growth factor I is
required for vessel remodeling in the adult brain. Proc Natl Acad Sci USA
2004, 101(26):9833-8.
Page 12 of 13
Page 13 of 13